IDD Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Innate Pharma SA

Watchlist Manager

Watchlist

Price: 1.598 EUR 4.44% Market Closed

Market Cap: €215.6m

I	Innate Pharma SA SWB:IDD	FR
A	Alstom SA F:AOMD	FR
	Banco Bilbao Vizcaya Argentaria SA F:BBVA	ES
K	Kyobo 18 Special Purpose Acquisition Company Co Ltd KOSDAQ:0041B0	KR
I	Intuitive Surgical Inc F:IUI1	US
	Byd Electronic (International) Co Ltd HKEX:285	CN
A	Abercrombie & Fitch Co DUS:AFT	US
F	Fuyo General Lease Co Ltd F:FXL	JP

Profitability Summary

Innate Pharma SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

48%

Strong 3Y Average Gross Margin

60%

Declining Gross Margin

93% > 48%

Negative Operating Margin

-1 125%

Negative 3Y Average Operating Margin

-732%

Declining Operating Margin

-152% > -1 125%

Negative Net Margin

-1 122%

Negative 3Y Average Net Margin

-700%

Declining Net Margin

-144% > -1 122%

Negative Free Cash Flow Margin

-1 012%

Negative 3Y Average Free Cash Flow Margin

-635%

Declining Free Cash Flow Margin

-74% > -1 012%

Exceptional ROE

268%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-257%

Declining ROIC

-55% > -274%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.